Breitmeyer James B has bought 2,250 shares of Oncternal Therapeutics, Inc. [ONCT] at $0.29 a share.
Oncternal Therapeutics, Inc. [ONCT] disclosed in an SEC Form 4 submission Thursday, April 13, 2023 that the deal increased Breitmeyer James B's holding in the company to 19,544.
Oncternal Therapeutics, Inc. [ONCT] is a Pharmaceutical Preparations company based in Delaware.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.